Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Homology Medicines Inc (NQ: FIXX )

1.830 -0.140 (-7.11%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 187,024
Open 1.960
Bid (Size) 1.810 (72)
Ask (Size) 2.960 (2)
Prev. Close 1.970
Today's Range 1.810 - 2.050
52wk Range 1.300 - 8.900
Shares Outstanding 57,385,578
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
79 Biggest Movers From Yesterday
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 154.7% to settle at $12.10 on Tuesday on continued strength after the FDA granted clearance for the company's pūrgo technology, classifying it... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga

Performance

YTD
-56.12%
-56.12%
1 Month
+24.49%
+24.49%
3 Month
-39.80%
-39.80%
6 Month
-50.27%
-50.27%
1 Year
-74.83%
-74.83%

More News

Read More
Analyst Ratings for Homology Medicines
Via Benzinga
Analyst Ratings for Homology Medicines
Via Benzinga
69 Biggest Movers From Friday
Via Benzinga
Homology Medicines, Inc. (NASDAQ:FIXX) Investor Notice: Deadline in Lawsuit on May 24, 2022
Via SBWire
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Homology Medicines, Inc. (FIXX) Shareholders of Class Action Last Few Hours to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
HOMOLOGY DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Homology Medicines, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
The Daily Biotech Pulse: Pfizer/BioNTech's COVID-19 Booster For Kids, Moderna Starts First African Trial Of mRNA HIV Vaccine, Tonix Extends COVID-19 Antiviral Research Pact
Via Benzinga
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Homology Medicines, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FIXX
Via NewMediaWire
ROSEN, A LEADING LAW FIRM, Encourages Homology Medicines, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important May 24 Deadline in Securities Class Action - FIXX
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Investor Action Reminder: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Investor Action Alert: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Shareholder Action Notice: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Shareholder Action Reminder: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Shareholder Action Reminder: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
ROSEN, A TOP RANKED LAW FIRM, Encourages Homology Medicines, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - FIXX
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Shareholder Action Alert: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Homology Medicines, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FIXX
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Investor Action Notice: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2022
Via Benzinga
Investor Action Reminder: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Investor Action Alert: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Shareholder Action Notice: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Shareholder Action Reminder: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.